Pharming Group Stock Price, News & Analysis (OTCMKTS:PHGUF)

$1.70 -0.05 (-2.86 %)
(As of 02/22/2018 04:00 PM ET)
Previous Close$1.70
Today's Range$1.61 - $1.71
52-Week Range$0.30 - $1.96
Volume31,429 shs
Average Volume4,751 shs
Market Capitalization$1.01 billion
P/E Ratio-15.91
Dividend YieldN/A
BetaN/A

About Pharming Group (OTCMKTS:PHGUF)

Pharming Group logoPharming Group NV (Pharming) is a Netherlands-based biotechnology company. The Company operates through two business segments, including Recombinant proteins, and DNage. Pharming focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. The Company’s products are aimed at treatments for genetic disorders and surgical and traumatic bleeding. Pharming’s technologies include novel transgenic platforms for the production of biopharmaceuticals, as well as technology and processes for the purification and formulation of these biopharmaceuticals. The Company’s commercial partners are: Santarus, Sobi, MegaPharm, Eczacibasi, Transmedic and Hyupjin. The Company operates worldwide. In March 2014, it announced downsizing of the Dutch operations following from strategic re-emphasis on collaborative development efforts and out-sourcing of non-core activities.

Receive PHGUF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PHGUF
CUSIPN/A
Phone+31-71-5247400

Debt

Debt-to-Equity Ratio11.47%
Current Ratio1.31%
Quick Ratio0.99%

Price-To-Earnings

Trailing P/E Ratio-15.9090909090909
Forward P/E Ratio-24.29
P/E GrowthN/A

Sales & Book Value

Annual Sales$17.57 million
Price / Sales56.02
Cash FlowN/A
Price / CashN/A
Book Value$0.07 per share
Price / Book24.29

Profitability

Trailing EPSN/A
Net Income$-19,400,000.00
Net Margins-69.48%
Return on Equity-259.69%
Return on Assets-33.75%

Miscellaneous

Employees94
Outstanding Shares579,020,000

Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) issued its quarterly earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.01. Pharming Group had a negative return on equity of 259.69% and a negative net margin of 69.48%. View Pharming Group's Earnings History.

When will Pharming Group make its next earnings announcement?

Pharming Group is scheduled to release their next quarterly earnings announcement on Thursday, March, 8th 2018. View Earnings Estimates for Pharming Group.

Who are some of Pharming Group's key competitors?

Who are Pharming Group's key executives?

Pharming Group's management team includes the folowing people:

  • Paul Jai Sekhri, Chairman of the Board of Supervisory Directors (Age 59)
  • Sijmen de Vries, Member of the Management Board, Chief Executive Officer (Age 58)
  • Juergen H. L. Ernst, Vice Chairman of the Board of Supervisory Directors (Age 78)
  • Robin Wright, Chief Financial Officer, Member of the Management Board (Age 53)
  • Bruno M. Giannetti, Member of the Management Board, Chief Operations Officer (Age 65)
  • Anne-Marie de Groot, Senior Vice President Organizational Development, Member of the Management Board
  • Jaap Blaak, Member of the Board of Supervisory Directors (Age 76)
  • Aad de Winter, Member of the Board of Supervisory Directors (Age 64)
  • Jan H. Egberts M.D., Member of the Board of Supervisory Directors (Age 58)
  • Jonh Barrie Ward Ph.D., Member of the Board of Supervisory Directors (Age 76)

How do I buy Pharming Group stock?

Shares of Pharming Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharming Group's stock price today?

One share of Pharming Group stock can currently be purchased for approximately $1.70.

How big of a company is Pharming Group?

Pharming Group has a market capitalization of $1.01 billion and generates $17.57 million in revenue each year. Pharming Group employs 94 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, LEIDEN, 2333 CR, Netherlands. The biotechnology company can be reached via phone at +31-71-5247400 or via email at inves[email protected]


MarketBeat Community Rating for Pharming Group (PHGUF)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  90 (Vote Underperform)
Total Votes:  148
MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pharming Group (OTCMKTS:PHGUF) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Pharming Group (OTCMKTS:PHGUF) Consensus Price Target History

Price Target History for Pharming Group (OTCMKTS:PHGUF)

Pharming Group (OTCMKTS:PHGUF) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/26/2017HC WainwrightReiterated RatingBuyView Rating Details
1/24/2017Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Pharming Group (OTCMKTS:PHGUF) Earnings History and Estimates Chart

Earnings by Quarter for Pharming Group (OTCMKTS:PHGUF)

Pharming Group (OTCMKTS PHGUF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/8/2018        
10/26/2017Q3 2017($0.01)($0.02)$18.76 million$30.06 millionViewN/AView Earnings Details
7/27/2017Q2 2017($0.02)($0.06)$17.80 million$16.69 millionViewN/AView Earnings Details
5/17/2017Q1 2017($0.01)$11.48 million$16.47 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.02)$7.75 millionViewN/AView Earnings Details
10/27/2016Q3 2016($0.01)$3.82 millionViewN/AView Earnings Details
7/28/2016Q2 2016($0.01)($0.01)$2.75 million$2.24 millionViewN/AView Earnings Details
5/18/2016Q1 2016($0.01)($0.01)$2.58 million$2.44 millionViewN/AView Earnings Details
3/10/2016Q4 2015($0.01)$4.01 million$2.57 millionViewN/AView Earnings Details
10/28/2015Q3 2015($0.01)$4.97 million$3.61 millionViewN/AView Earnings Details
7/30/2015Q2 2015($0.01)$2.12 million$3.82 millionViewN/AView Earnings Details
3/5/2015$0.04$0.05ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Pharming Group (OTCMKTS:PHGUF) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.07 EPS
Next Year EPS Consensus Estimate: $0.07 EPS

Dividends

Dividend History for Pharming Group (OTCMKTS:PHGUF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pharming Group (OTCMKTS PHGUF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Pharming Group (OTCMKTS PHGUF) News Headlines

Source:
DateHeadline
Pharming Group (PHGUF) Upgraded by Zacks Investment Research to "Strong-Buy"Pharming Group (PHGUF) Upgraded by Zacks Investment Research to "Strong-Buy"
www.americanbankingnews.com - January 20 at 9:24 AM
Pharming Group (PHGUF) Rating Lowered to Hold at Zacks Investment ResearchPharming Group (PHGUF) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - December 5 at 6:58 AM
Pharming Group (PHGUF) Rating Lowered to Sell at ValuEnginePharming Group (PHGUF) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - December 2 at 9:10 PM

SEC Filings

Pharming Group (OTCMKTS:PHGUF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Pharming Group (OTCMKTS PHGUF) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.